atypical antipsychotics increasing mortality in elderly patients with dementia
June 2005
See updated information from the FDA
You'll see new boxed warnings about atypical antipsychotics increasing mortality in elderly patients with dementia.
This creates a real dilemma.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote